XML 48 R34.htm IDEA: XBRL DOCUMENT v3.22.1
Stockholders’ Equity, Warrants, Debentures and Guaranty (Tables)
12 Months Ended
Dec. 31, 2021
Stockholders' Equity Note [Abstract]  
Schedule of Warrants issued in November and December 2021
  Series A
Warrants
Series B
Warrants
Series C
Warrants
Monroe
Warrants
Series D
Warrants
Date issued 11/5/2021 11/5/2021 12/2/2021 12/2/2021 12/15/2021
Number of warrants issued at inception Between 2,500,000 and 5,000,000 2,500,000 1,500,000 Between 2,519,557 and 5,016,704 (3) 15,625,000
Issued in connection with Sale of 2,500,000 shares of common stock Sale of
2,500,000
shares of
common stock
Modification of Series A Warrants and  Series B Warrants Monroe Credit Facility Sale of 7,840,000 shares of common stock and 12,456 units of Series A Preferred Stock
Exercise price on issuance date $2.00 $2.00 $0.0001 $0.0001
$2.00 (5)
Exercise price modified after issue date? Yes Yes No No No
Date of modification, if modified 12/2/2021 12/2/2021 NA - not modified NA - not
modified
NA - not
modified
Assuming no antidilution triggers occur, maximum number of warrants issuable as of the modification date, if modified 6,666,667 (4) 3,333,334 NA - not modified NA - not
modified
NA - not
modified
Modified exercise price, if modified during 2021 $1.50 (5) $1.50 (5) NA - not modified NA - not
modified
NA - not
modified
Maturity date of warrant 11/5/2026 11/5/2023 (1) 12/2/2026 1/31/2029 12/15/2026 (2)
Underlying shares registered? No, on the issuance date; Yes, as of 12/10/21 Yes, beginning on the issuance date Yes, beginning on the issuance date No, on the issuance date; Yes, as of 2/9/22 No, on the issuance date; Yes, as of 1/7/22
Fair value per warrant as of issuance date $0.92 $0.35 $1.48 $1.48 $0.63
Fair value per warrant as of modification date, if modified $0.80 $0.45 NA - not modified NA - not
modified
NA - not
modified
Amounts and dates of warrants exercised during the year  NA 1,800,000 on 12/10/21
700,000 on 12/29/21
833,334 on 12/30/21
1,500,000 on 12/8/21  NA  NA
Fair value per warrant on exercise date(s) NA $0.91 on 12/10/21
$1.00 on 12/29/21
$1.00 on 12/30/21
$1.03 on 12/8/21 NA NA
Warrants exercisable as of 12/31/21 6,666,666  - - 2,519,557 15,625,000
Valuation basis Black-Scholes  Monte Carlo
Simulation
Stock price Stock price  Monte Carlo
Simulation
Fair value per warrant as of 12/31/21, if outstanding $1.52 NA NA $2.43 $1.25
Assumptions used in estimating fair values:          
◦ stock price volatility 60% - 65% 60% - 65% NA NA 60% - 65%
◦ exercise price $1.50 - $2.00 $1.50 - $2.00 NA NA $2.00
◦ discount rate 1.04% - 1.24% 0.39% - 0.68% NA NA 1.25% - 1.26%
◦ remaining useful life (in years) 4.85 - 5.00 1.85 - 2.00 NA NA 4.96 - 5.00
◦ stock price $1.48 - $2.43 $1.48 - $2.43 $1.03 - $1.48 $1.48 - $2.43 $1.53 - $2.43

Schedule of Debenture components prior to conversion
       Discount consisting of     
       relative fair     
   Principal   value of Penny
Warrants
   Net 
Issued on the Computex Closing Date  $43,169   $(9,937)  $33,232 
Issued in the Successor periods:               
Issued to Ribbon   43,778    (14,159)   29,619 
Issued to SPAC Opportunity Partners, LLC   17,990    (6,249)   11,741 
Other issuances (various holders)   17,010    (6,610)   10,400 
   $121,947   $(36,955)  $84,992 
Amortization of discount             12,752 
Paid-in-kind interest             11,951 
Deferred financing fees             (523)
Net Debentures as of September 8, 2021, prior to conversion            $109,172 
Less reduction due to conversion             (109,172)
Balance at September 8, 2021, after conversion            $
-
 
Financial statement line items impacted by the conversion:               
Additional paid in capital            $109,691 
Common stock (38,811,223 shares at par value of $0.0001 per share)             4 
Interest expense - write off of deferred financing fees             (523)
             $109,172